# Drugs of Abuse Testing Market and Forecast 2025-2033

Limited-Time Offer \[Flat 15% Discount\] [Dismiss](#)

[Skip to content](#content "Skip to content")

[Updated Data Matrix Available](https://www.ihealthcareanalyst.com/research-services/)

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

[Home](https://www.ihealthcareanalyst.com/) » [Reports](https://www.ihealthcareanalyst.com/shop/) » [Medical Devices](https://www.ihealthcareanalyst.com/reports/medical-devices/)

![Awaiting product image](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)

![Awaiting product image](https://www.ihealthcareanalyst.com/wp-content/uploads/2019/08/report-icon4-e1565791186498.png)

# Drugs of Abuse Testing Market by Sample Type (Blood, Breath, Hair & Sweat, Saliva, Urine), Product Type (Analyzers – Breath Analyzers, Chromatographic Devices, Immunoassays Analyzers, Rapid Testing Devices – Oral Fluid Testing Devices, Urine Testing Devices, Consumables, Fluid Collection Devices, Others), Test Type (Criminal Justice Testing, Pain Management Testing, Work Place Screening), End Users (Diagnostics Laboratories, Forensic Laboratories, Hospitals, On-Site Testing) and Forecast 2025-2033

$3,000.00

## Report Specifications: Market Size, Market Share, Growth Trends, Forecast, Geography

Drugs of abuse testing is used to screen for and confirm the presence of several drugs in a person’s sample, such as urine, blood, breath, saliva or hair. Drug testing is used so that a person may receive appropriate medical treatment or be screened for or monitored for illegal drug use. Some of the most commonly screened drugs include amphetamine and methamphetamine, barbiturates such as phenobarbital, secobarbital and pentobarbital, benzodiazepines such as diazepam, lorazepam and oxazepam, marijuana, cocaine, methadone, opiates, such as heroin, codeine and morphine, and phencyclidine. Drugs of abuse testing may be used for medical screening, legal or forensic information, employment drug testing, sports or athletics testing, and monitoring pain medication use.

The global drugs of abuse testing market segmentation is based on sample type (blood, breath, hair & sweat, saliva, urine), product type (analyzers – breath analyzers, chromatographic devices, immunoassays analyzers, rapid testing devices – oral fluid testing devices, urine testing devices, consumables, fluid collection devices, others), test type (criminal justice testing, pain management testing, work place screening), end users (diagnostics laboratories, forensic laboratories, hospitals, on-site testing).

The global drugs of abuse testing market report provides market size ($Million 2023 to 2033), market share, trends and forecast (CAGR%, 2025 to 2033). The global drugs of abuse testing market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global drugs of abuse testing market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.

Major players operating in the global drugs of abuse testing market and profiled in this report include Abbott Laboratories, Inc., Drägerwerk AG & Co. KGaA, Express Diagnostics International, Inc., F. Hoffmann La-Roche Ltd, Laboratory Corporation of America Holdings, Shimadzu Corporation, Siemens Healthineers, and Thermo Fisher Scientific, Inc.

**DATA INCLUDED:** Drugs of Abuse Testing Market Size, Drugs of Abuse Testing Market Share, Drugs of Abuse Testing Market Growth Rates, Drugs of Abuse Testing Market Trends, and Drugs of Abuse Testing Market Forecast to 2033

**Market Data:**

*   Estimation Base Year: 2024
*   Historical Data Range: 2023-2024
*   Forecast Period: 2025-2033
*   Market Representation: Revenue in $million and CAGR % from 2025 to 2033
*   Regional Scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
*   Country Scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE, and other countries.
*   Report Coverage: Revenue forecasts, company market share, competitive landscape analysis, growth factors, and market trends
*   Customization Scope (15% Free): Accommodation of specific or custom requirements beyond the current report scope.

**Qualitative Analysis:**

*   Industry Overview
*   Industry Trends
*   Market Driver, Restraints, and Opportunities
*   Market Size
*   Growth Trends
*   Porter’s Five Forces Analysis
*   Market Attractiveness Matrix
*   Competitive Landscape
    *   Company Overview
    *   Financial Performance
    *   Product Portfolio
    *   Strategic Insights
    *   Recent Developments

**Quantitative Analysis:**

*   Market Size Projections: Comprehensive estimates and forecasts for all segments
*   Regional Market Analysis: Estimates and forecasts for key countries
*   Corporate Financial Performance: Analysis of company financials
*   Competitive Landscape: Market share analysis of leading companies

Choose License Type

Choose an optionSingle-user LicenseMulti-user LicenseCorporate License[Clear](#)

Drugs of Abuse Testing Market by Sample Type (Blood, Breath, Hair & Sweat, Saliva, Urine), Product Type (Analyzers - Breath Analyzers, Chromatographic Devices, Immunoassays Analyzers, Rapid Testing Devices - Oral Fluid Testing Devices, Urine Testing Devices, Consumables, Fluid Collection Devices, Others), Test Type (Criminal Justice Testing, Pain Management Testing, Work Place Screening), End Users (Diagnostics Laboratories, Forensic Laboratories, Hospitals, On-Site Testing) and Forecast 2025-2033 quantity 

Buy Report   

For inquiries regarding discounts on single or bundled report purchases, please reach out to us.

*   [Table of Contents MD](#tab-table-of-contents-md)
*   [Market Segments and Companies](#tab-market-segments-and-companies)
*   [Request ToC / Sample](#tab-request-toc-sample-pages)

1.  **Introduction**
2.  **Executive Summary**
    *   Market Size Estimation ($million, 2023-2033)
    *   Forecast Estimation ($million and CAGR%, 2025-2033)
3.  [**Research Methodology**](https://www.ihealthcareanalyst.com/research-methodology/)
4.  **Market Landscape**
    *   Market Dynamics
        *   Drivers
        *   Barriers
        *   Opportunities
    *   Market Share Analysis
        *   Companies
        *   Devices
    *   Market Trends Analysis
        *   Key success factors
        *   Market Growth Rate
    *   Market Attractiveness Analysis
    *   Market Profitability Analysis
        *   Buyer power
        *   Supplier power
        *   Barriers to entry
        *   Threat of substitute products
        *   Rivalry among firms in the industry
    *   Distribution Channels
5.  **Market Segmentation** \[_refer Market Segments and Companies Tab_\]
    *   Device or Brand Type
    *   Diagnostic Test
    *   Indication Type
    *   Technology
    *   Diagnostics, Therapeutic or Surgical Application
    *   End User Groups
6.  **Geography (Region, Country)**
    *   North America (U.S., Canada)
    *   Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    *   Asia Pacific (Japan, China, India, Rest of APAC)
    *   Latin America (Brazil, Mexico, Rest of LA)
    *   Rest of the World (Middle East & Africa)
7.  **Regulatory Overview** 
    *   Device Classification I, II, III, IV
    *   Device (FDA, EMEA) Approvals
8.  **Company Profiles** \[_refer Market Segments and Companies Tab_\]
    *   Company Overview
    *   Financial Snapshot
    *   Product Portfolio
    *   Business Strategies
    *   Recent Developments
9.  **Recommendations**
10.  **References**

**Key Questions Answered:**  
1\. What are the factors driving and limiting this market, key success factors and challenges?  
2\. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?  
3\. How do markets perform between countries and regions?  
4\. What market segments are contributing to maximum share and greatest growth?  
5\. What is the product or procedure volumes by country and regions?

**Actionable Insights Included:**  
1\. Product portfolio matrix (Share vs. Growth)  
2\. Market attractiveness (Region vs. Growth)  
3\. Spot matrix (Product vs. Region)  
4\. Geographic distribution matrix (Share vs. Growth)

**Drugs of Abuse Testing Market**

1\. **Sample Type**  
1.1. Blood  
1.2. Breath  
1.3. Hair & Sweat  
1.4. Saliva  
1.5. Urine

2\. **Product Type**  
2.1. Analyzers  
2.1.1. Breath Analyzers  
2.1.2. Chromatographic Devices  
2.1.3. Immunoassays Analyzers  
2.2. Rapid Testing Devices  
2.2.1. Oral Fluid Testing Devices  
2.2.2. Urine Testing Devices  
2.3. Consumables  
2.3.1. Fluid Collection Devices  
2.4. Others

3\. **Test Type**  
3.1. Criminal Justice Testing  
3.2. Pain Management Testing  
3.3. Work Place Screening

4\. **End Users**  
4.1. Diagnostics Laboratories  
4.2. Forensic Laboratories  
4.3. Hospitals  
4.4. On-Site Testing

5\. **Geography (Region, Country)**  
5.1. North America (U.S., Canada)  
5.2. Latin America (Brazil, Mexico, Rest of LA)  
5.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)  
5.4. Asia Pacific (Japan, China, India, Rest of APAC)  
5.5. Rest of the World

6\. **Company Profiles**  
6.1. Abbott Laboratories, Inc.  
6.2. Drägerwerk AG & Co. KGaA  
6.3. Express Diagnostics International, Inc.  
6.4. F. Hoffmann La-Roche Ltd  
6.5. Laboratory Corporation of America Holdings  
6.6. Shimadzu Corporation  
6.7. Siemens Healthineers  
6.8. Thermo Fisher Scientific, Inc.

**Request Table of Contents / Sample Report**

Full Name\*

Company Email\*

Phone Number\* \[Please add country code\]

Subject\*

Message\*

Resource Links

*   [About Us](https://www.ihealthcareanalyst.com/about/)
*   [Clinical Trials](https://www.ihealthcareanalyst.com/clinical-trials-dashboard/)
*   [Drugs@FDA](https://www.ihealthcareanalyst.com/drugs-fda-dashboard/)
*   [Orange Book](https://www.ihealthcareanalyst.com/orange-book-dashboard/)
*   [Premarket Approval](https://www.ihealthcareanalyst.com/premarket-approval-pma/)
*   [Premarket Notification](https://www.ihealthcareanalyst.com/premarket-notification-510k/)
*   [Publications](https://www.ihealthcareanalyst.com/publications/)

Terms and Conditions

*   [FAQs](https://www.ihealthcareanalyst.com/faqs/)
*   [Careers](https://www.ihealthcareanalyst.com/careers/)
*   [Terms of Use](https://www.ihealthcareanalyst.com/terms/)
*   [How to Order](https://www.ihealthcareanalyst.com/order/)
*   [Return Policy](https://www.ihealthcareanalyst.com/return/)
*   [Privacy Policy](https://www.ihealthcareanalyst.com/privacy/)
*   [Disclaimer Policy](https://www.ihealthcareanalyst.com/disclaimer/)

Secure Online Payment

![iHealthcareAnalyst, Inc.](https://www.ihealthcareanalyst.com/wp-content/uploads/2018/07/creditcard-payment-logos-300x48.jpg)

Search

Search

Contact Address

**US Office:** 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States  
Phone: +1 (314) 315-4764  
**India Office:** 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India  
Phone: +91 (20) 25898524  
Email: [\[email protected\]](/cdn-cgi/l/email-protection#651604090016250c0d000409110d06041700040b04091c16114b060a08)

[](# "Scroll back to top")

Search for: